New York Blood Center National Cord Blood Program | Aplastic Anemia and MDS International Foundation

Clinical Trial: NCT00212407

New York Blood Center National Cord Blood Program
For more details on this clinical trial, including contact information, please see this trial’s listing on

Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid and platelet engraftment, transplant related mortality, overall survival, graft vs. host disease and, for patients with leukemia, lymphoma or myelodysplasia, relapse.

Study Date: 
Mon, 02/01/1993 to Tue, 12/01/2020
Bone Marrow Disease(s): 
myelodysplastic syndromes (MDS)
Biological: Umbilical Cord Blood Transplantation Other Name: One or more matched umbilical cord blood units for transplant